◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

ENVERIC BIOSCIENCES, INC.

CIK: 890821 SIC: 2834
-
Revenue
$-9.73M
Net Income
-
Gross Margin
-
Op. Margin
$-14.34M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 10 of 10 annual reports available (2011 - 2024)
Breakdown TTM
(Sep 30, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
FY 2011
(Dec 31, 2011)
+ Total Revenue - - - - - $43.00M $48.59M - - - -
Revenue Growth % nan% nan% nan% nan% nan% -11.5% nan% nan% nan% nan% nan%
Cost of Revenue - - - - - $34.01M $38.36M - - - -
+ Gross Profit - - - - - $8.98M $10.24M - - - -
Gross Margin % nan% nan% nan% nan% nan% 20.9% 21.1% nan% nan% nan% nan%
Operating Expenses - - - - - $16.13M $22.21M - - - -
Research & Development $3.51M $2.84M $7.25M $4.79M $174.08K - - - - - -
Selling General & Admin - - - $20.50M $5.44M $10.79M $18.51M - - - -
+ Operating Income $-9.75M $-9.63M $-16.45M $-64.62M $-5.62M $-7.15M $-11.97M $32.81K $27.21K $-22.69K $-31.39K
Operating Margin % nan% nan% nan% nan% nan% -16.6% -24.6% nan% nan% nan% nan%
Interest Expense - - - $10.32K $445.25K $729.90K $575.04K - - - -
Other Income/Expense - $66.21K $-814.38K $8.19M $1.25M $-3.40M $504.11K - - - -
Income Before Tax $-9.73M $-9.57M $-17.26M $-56.43M $-6.86M $-10.55M $-11.47M $-32.81K $1.29K $-22.69K $-31.39K
Income Tax Expense - $8.93K $28.91K $-7.45M - $6.35M $-2.39M $833.00 $1.45K $1.93K $1.99K
+ Net Income $-9.73M $-9.57M $-17.29M $-48.98M $-6.86M $-16.90M $-9.07M $-33.64K $-161.00 $-24.62K $-33.38K
Net Margin % nan% nan% nan% nan% nan% -39.3% -18.7% nan% nan% nan% nan%
Basic EPS -31.09 -19.04 -8.09 nan nan -0.82 -0.75 nan nan nan nan
Diluted EPS -31.09 -19.04 -8.09 nan nan -0.82 -0.75 nan nan nan nan
Basic Shares Outstanding 313K 503K 2.2M - 5.8M 23.8M 15.0M 15.2M 12.1M 12.1M 8.5M
Diluted Shares Outstanding 313K 503K 2.2M - - 23.8M 15.0M - - - -
Breakdown FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
FY 2011
(Dec 31, 2011)
Cash & Cash Equivalents $2.24M $2.29M $17.36M $1.58M $1.37M $4.88M $5.08K $249.00 $1.38K $18.23K
Accounts Receivable - - - - $7.87M $8.84M - - - -
Other Current Assets $493.56K $1.29M $380.84K $700.71K $818.60K $924.27K - $4.22K $4.22K $4.22K
Total Current Assets $2.73M $3.58M $17.74M $2.28M $10.06M $14.64M $5.08K $4.47K $5.60K $22.45K
Property Plant & Equipment $305.78K $507.38K $294.43K - $58.89K $95.05K - - - -
Goodwill - - $1.59M - $13.73M $21.90M - - - -
Intangible Assets $42.18K $210.93K $6.92M $1.82M $5.78M $9.47M - - - -
Total Assets $3.08M $4.30M $26.72M $4.10M $29.64M $52.20M $5.08K $4.47K $5.60K $22.45K
Accounts Payable $521.75K $1.22M - - $4.38M $5.32M - - - -
Accrued Liabilities $732.01K $1.08M $1.29M - - - - - - -
Other Current Liabilities - $23.61K - - - - - - - -
Total Current Liabilities $1.49M $2.34M $2.08M $681.25K $14.69M $30.37M $8.96K $24.70K $25.67K $17.89K
Long-term Debt - - - - - $1.13M - - - -
Total Liabilities - - $4.41M $681.25K $18.88M $32.75M - - - -
Common Stock $6.78K $27.39K $325.79K $100.95K $423.29K $181.62K $171.42K $121.42K $121.42K $121.42K
Retained Earnings $-106.07M $-96.50M $-60.74M $-11.76M $-34.48M $-15.00M $-47.43M $-47.39M $-47.39M $-47.37M
Total Stockholders Equity $1.59M $1.96M $22.31M $3.42M $-65.45K $19.45M $-3.87K $-20.23K $-20.07K $4.55K
Total Liabilities & Equity $3.08M $4.30M $26.72M $4.10M $29.64M $52.20M $5.08K $4.47K $5.60K $22.45K
Breakdown TTM
(Sep 30, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
FY 2011
(Dec 31, 2011)
Net Income $-11.92M $-9.57M $-17.29M $-48.98M $-6.86M $-16.90M $-9.07M $-33.64K $-161.00 $-24.62K $-33.38K
Depreciation & Amortization $243.86K $337.49K $343.98K $656.64K $120.87K $2.90M $3.22M - - - -
Stock-based Compensation $1.65M $1.56M $2.15M - $1.98M - $7.08M - - - -
Deferred Income Tax - - - - - - $-2.39M - - - -
Change in Receivables - - - - - $-967.03K $778.54K - - - -
Operating Cash Flow $-14.34M $-7.73M $-14.09M $-11.46M $-3.89M $-2.57M $-2.74M $-43.16K $-21.63K $-24.85K $-30.35K
Capital Expenditure - - $5.18K - - - - - - - -
Acquisitions - - - - - $3.65M $804.04K - - - -
Investing Cash Flow - - $11.67K $2.19M $-44.14K $-3.64M $-808.88K - - - -
Stock Issued - $2.29M - $21.61M $488.00K $6.33M $4.90M $50.00K $100.00K - $20.00K
Financing Cash Flow $17.70M $7.67M $-1.34M $24.90M $5.53M $2.69M $7.05M $48.00K $20.50K $8.00K $47.45K
Net Change in Cash $3.31M $-46.95K $-15.44M $15.78M $1.53M $-3.51M $3.50M $1.38K $-1.13K $-16.85K $17.11K
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Research & Development $402.42K - $2.41M -
Operating Income $-1.87M - $-6.58M -
Interest Expense - - - -
Other Income/Expense - - $2.56K -
Income Before Tax $-1.87M - $-6.58M -
Income Tax Expense - - - -
Net Income $-1.87M $-1.88M $-6.58M -
Basic EPS -10.81 - -35.74 -
Diluted EPS -10.81 - -35.74 -
Basic Shares Outstanding $313.24K - $226.40K -
Diluted Shares Outstanding $313.24K - $226.40K -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $3.76M $2.24M
Other Current Assets $407.95K $493.56K
Total Current Assets $4.17M $2.73M
Property Plant & Equipment $196.52K $305.78K
Intangible Assets - $42.18K
Total Assets $4.36M $3.08M
Accounts Payable $683.71K $521.75K
Other Current Liabilities - $232.89K
Total Current Liabilities $905.88K $1.49M
Common Stock $5.18K $565.00
Retained Earnings $-112.65M $-106.07M
Total Stockholders Equity $3.46M $1.59M
Total Liabilities & Equity $4.36M $3.08M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-1.87M $-1.88M $-6.58M -
Depreciation & Amortization $40.37K - $161.37K -
Stock-based Compensation - - $587.09K -
Operating Cash Flow - - $-6.36M -
Stock Issued - - - -
Financing Cash Flow - - $7.89M -
Net Change in Cash - - $1.52M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading news...
TRENDING
Loading...